Motley Fool Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Motley Fool Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-624,780	Closed	-$5.65M	–	78
2016 Q1	$5.65M	Buy	624,780 +73,895	+13%	+$661K	1.18%	39
2015 Q4	$5.78M	Sell	550,885 -73,895	-12%	-$809K	1.16%	37
2015 Q3	$7.99M	Hold	624,780	–	–	1.56%	20
2015 Q2	$6.91M	Hold	624,780	–	–	1.23%	35
2015 Q1	$7.13M	Hold	624,780	–	–	1.26%	33
2014 Q4	$6.29M	Hold	624,780	–	–	1.18%	35
2014 Q3	$6.57M	Hold	624,780	–	–	1.36%	29
2014 Q2	$5.39M	Hold	624,780	–	–	1.16%	33
2014 Q1	$5.49M	Hold	624,780	–	–	1.27%	32
2013 Q4	$5.13M	Hold	624,780	–	–	1.29%	32
2013 Q3	$4.72M	Hold	624,780	–	–	1.41%	28
2013 Q2	$4.73M	Buy	+624,780	New	+$4.56M	1.72%	23

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Motley Fool Asset Management's RDY Position: Q2 2016 in Review

Motley Fool Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2016, closing a stake of 624,780 shares — an estimated $5.65M sold.

Motley Fool Asset Management first reported a position in RDY in Q2 2013 and held it in 12 quarters. The position peaked at $7.99M in Q3 2015. 157 funds tracked by Wall St. Rank hold RDY as of Q2 2016.

Motley Fool Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2016 after selling out during the quarter.
Motley Fool Asset Management sold 624,780 Dr. Reddy's Laboratories shares in Q2 2016, an estimated $5.65M.
Motley Fool Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 12 quarters.
Motley Fool Asset Management's Dr. Reddy's Laboratories position peaked at $7.99M in Q3 2015.
157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2016.

Based on Motley Fool Asset Management's 13F filing for Q2 2016, filed 5 Aug 2016.